Pharmaniaga Berhad Cash Flow Statement

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	42.36	131.82	-80.16	-629.92	172.15
Depreciation & Amortization	27.18	38.35	38.77	34.02	31.7
Other Amortization	6.06	3.03	2.93	2.41	1.68
Other Operating Activities	-93.29	-130.53	85.41	451.15	-269.58
Operating Cash Flow	-17.69	42.67	46.95	-142.34	-64.06
Operating Cash Flow Growth	-	-9.12%	-	-	-
Capital Expenditures	-29.78	-31.16	-50.67	-59.26	-30.39
Sale of Property, Plant & Equipment	0.29	0.08	1.32	0.06	0.21
Sale (Purchase) of Intangibles	-8.89	-8.41	-10.34	-18.38	-14.97
Other Investing Activities	-141.86	-6.13	-8.24	5.25	-0.41
Investing Cash Flow	-180.24	-45.62	-67.93	-72.34	-45.56
Short-Term Debt Issued	-	-	50	-	-
Long-Term Debt Issued	-	2,150	3,248	2,291	2,329
Total Debt Issued	-	2,150	3,298	2,291	2,329
Short-Term Debt Repaid	-50	-	-	-	-
Long-Term Debt Repaid	-349.55	-2,139	-3,240	-1,988	-2,149
Total Debt Repaid	-399.55	-2,139	-3,240	-1,988	-2,149
Net Debt Issued (Repaid)	-399.55	10.67	57.48	303.42	179.73
Issuance of Common Stock	569.57	-	45.86	-	-
Common Dividends Paid	-	-	-7.86	-82.53	-58.95
Other Financing Activities	-5.4	11.43	-0.21	-0.1	-0.04
Financing Cash Flow	164.62	22.1	95.27	220.79	120.74
Foreign Exchange Rate Adjustments	-2.18	-0.52	0.31	-0.39	0.13
Net Cash Flow	-35.49	18.64	74.59	5.74	11.25
Free Cash Flow	-47.47	11.51	-3.72	-201.6	-94.44
Free Cash Flow Margin	-1.21%	0.31%	-0.11%	-5.79%	-1.96%
Free Cash Flow Per Share	-0.01	0.01	-0.00	-0.15	-0.07
Cash Interest Paid	62.53	68.11	60.81	41.29	32.63
Cash Income Tax Paid	28.43	33.89	20.56	39.52	39.7
Levered Free Cash Flow	-75.83	-16.53	31.75	479.12	-143.76
Unlevered Free Cash Flow	-37.49	28.45	70.4	504.15	-122.93

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.